Episodes

  • From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi

    From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
    Dec 18 2024
    Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as physiological monitoring, meditation, and even generating multi-track Indian classical music. He’s published award-winning research on EEG spectral analysis and adaptive quiz generation using large language models, participated in over 12 AI hackathons—winning two—and is now a Prompt Engineer at Morgan Stanley, where he fine-tunes cutting-edge LLM interactions for real-world applications. In this episode we explore how AI is redefining stress management and revolutionizing real-time physiological data applications. Tune in to learn about the world of generative artificial intelligence— and looking at its transformative potential in mental health and stress management.
    Show more Show less
    32 mins
  • How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD

    How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
    Dec 3 2024
    Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode, Dr. Randy Teel discusses the company's PROTAC protein degrader technology platform and its pipeline of clinical-stage assets, with a focus on vepdegestrant, the company's lead asset that is being co-developed together with partner Pfizer, for the treatment of women with early and locally advanced or metastatic ER+/HER2- breast cancer.
    Show more Show less
    36 mins
  • The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024

    The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
    Nov 12 2024
    HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.
    Show more Show less
    26 mins
  • How NGGT is Pioneering the Next Wave of Gene Therapies

    How NGGT is Pioneering the Next Wave of Gene Therapies
    Oct 10 2024
    Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.
    Show more Show less
    40 mins
  • Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

    Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
    Sep 18 2024
    Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3
    Show more Show less
    38 mins
  • Left Behind: Addressing Health Equity for the Rare Disease Patient Community

    Left Behind: Addressing Health Equity for the Rare Disease Patient Community
    Sep 9 2024
    In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiWTycLm7wjK_LX0ZI
    Show more Show less
    21 mins
  • Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

    Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
    Sep 5 2024
    In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
    Show more Show less
    30 mins
  • Unlocking AI In Oncology with James Zou, PhD

    Unlocking AI In Oncology with James Zou, PhD
    Aug 27 2024
    In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford University, shares current use cases for AI in healthcare and oncology and discusses how we can overcome challenges with LLMs to unlock the full potential of AI.
    Show more Show less
    25 mins